Organigram grew its revenue more than 400 percent but missed on the top and bottom lines when it reported fourth-quarter financial results this morning. Shares of the Canadian cannabis producer were fairly stable in afternoon trading as the company looks to phase two of cannabis legalization. Cheddar's own cannabis reporter Chloe Aiello spoke with Organigram CEO Greg Engel to discuss these results.